Chevallier B, Perrocheau G
Centre régional de lutte contre le cancer H Becquerel, Rouen, France.
Bull Cancer. 1995;82 Suppl 1:9s-15s.
The efficacy of cytotoxic chemotherapy when administered at conventional doses in breast cancer is limited and allows to understand some failures in the adjuvant, advanced or inflammatory and also in metastatic settings. The use of high dose chemotherapy is one way to try to improve its efficacy based on response rate, overall and disease free survival. Retrospective analysis on dose efficacy in breast cancer suggest that the results obtained by cytotoxic chemotherapy are linked to the administered dose without being able to assess this hypothesis with certainty. In 1995, the concept of dose efficacy remains to be validated by the appropriate prospective randomized trials.
细胞毒性化疗以常规剂量用于乳腺癌时疗效有限,这有助于理解辅助治疗、晚期或炎性以及转移情况下的一些治疗失败原因。使用高剂量化疗是基于缓解率、总生存期和无病生存期来试图提高其疗效的一种方法。对乳腺癌剂量疗效的回顾性分析表明,细胞毒性化疗所获得的结果与给药剂量有关,但无法确切评估这一假设。1995年,剂量疗效的概念仍有待通过适当的前瞻性随机试验来验证。